Skip to main content
Clinical Trials/NCT00348179
NCT00348179
Completed
Not Applicable

Vascular Function in Adolescent, Diabetic Children

Children's Mercy Hospital Kansas City1 site in 1 country85 target enrollmentApril 2004
ConditionsType 1 Diabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 1 Diabetes
Sponsor
Children's Mercy Hospital Kansas City
Enrollment
85
Locations
1
Primary Endpoint
Vascular abnormalities as measured by the SyphmgnoCor equipment
Status
Completed
Last Updated
18 years ago

Overview

Brief Summary

The objectives of this investigator initiated study are to:

  1. Determine if and when vascular abnormalities occur during early adolescence
  2. Determine if poor diabetic control is related to vascular abnormalities.

The development of vascular plaques and vascular contractility will be assessed through the use of the SyphmgnoCor equipment.

Detailed Description

Up to 85 Type 1 diabetic and healthy controls, 12-14 years of age, will be recruited for the study. Once the Permission/Assent form has been completed, a cuff will be applied to the arm and the pressure tonometer will be used on various vessels. Cardiovascular data will be recorded. The procedure is non-invasive, will last approximately 10 minutes and will be performed during a routine clinic visit. Onset of diabetes and level of diabetic control as measured by the most recent Hbg A1c (relative to the study visit) will be obtained from the medical record. Microalbumin levels covering the prior 12 months will be collected from the medical record of diabetic subjects.

Registry
clinicaltrials.gov
Start Date
April 2004
End Date
April 2007
Last Updated
18 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Children's Mercy Hospital Kansas City

Eligibility Criteria

Inclusion Criteria

  • Boys and girls ages 12-14 years who have Type 1 diabetes or are healthy controls

Exclusion Criteria

  • Children and adolescents who do not meet inclusion criteria

Outcomes

Primary Outcomes

Vascular abnormalities as measured by the SyphmgnoCor equipment

Time Frame: End of study

Study Sites (1)

Loading locations...

Similar Trials